Back to Journals » OncoTargets and Therapy » Volume 9

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway

Total article views   HTML views PDF downloads Totals
5,859 Dovepress* 5,248+ 1,258 6,506
PubMed Central* 611 144 755
Totals 5,859 1,402 7,261
*Since 20 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar